Zhongsheng Beikong Biotechnology (08247) announced its 2023 annual results. Shareholders should account for a loss of 11.648 million yuan

Zhongsheng Beikong Biotechnology (08247) announced its annual results for the year ended December 31, 2023, with revenue reaching...

Zhitong FinanceMar 27 19:31 ET

BIOSINO BIO-TEC: Annual Report 2023

Futu NewsMar 27 18:18 ET · Announcements

BIOSINO BIO-TEC: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

Futu NewsMar 27 18:14 ET · Announcements

Zhongsheng Beijing Holdings Biotechnology (08247) issued a profit warning. The net loss for the year is expected to increase from 18 million yuan to 22 million yuan over the same period last year

According to the Zhitong Finance App, Zhongsheng Beijing Holdings Biotechnology (08247) issued an announcement. It is expected that the Group will have a net loss of RMB 18 million to RMB 22 million for the year ended December 31, 2023, while net profit of about RMB 14.202 million for the year ended December 31, 2022. According to the announcement, the expected losses during the reporting period were mainly due to changes in domestic and foreign public health prevention and control policies, a decline in market demand; and a decrease in the Group's gross profit due to falling product prices due to centralized procurement in the industry; and the Group's superior products (such as flow cytometry and

Zhitong FinanceMar 18 06:43 ET

BIOSINO BIO-TEC: PROFIT WARNING

Futu NewsMar 18 06:41 ET · Announcements

Little Excitement Around Biosino Bio-Technology and Science Incorporation's (HKG:8247) Revenues As Shares Take 31% Pounding

To the annoyance of some shareholders, Biosino Bio-Technology and Science Incorporation (HKG:8247) shares are down a considerable 31% in the last month, which continues a horrid run for the company.

Simply Wall StFeb 8 17:04 ET